Amongst the various types of
cancer, breast cancer is a highly heterogeneous disease and known as the leading cause of death among women globally. The extensive interdisciplinary investigation in nanotechnology and
cancer biomedical research has been evolved over the years for its effective treatment. However, the advent of chemotherapeutic resistance in
breast cancer is one of the major confront researchers are facing in achieving successful
chemotherapy. Research in the area of
cancer nanotechnology over the years have now been revolutionized through the development of
smart polymers,
lipids, inorganic materials and eventually their surface-engineering with targeting
ligands. Moreover, nanotechnology further extended and brings in the notice the new
theranostic approach which combining the
therapy and imaging simultaneously. Currently, research is being envisaged in the area of novel nano-pharmaceutical design viz.
liposome, nanotubes,
polymer lipid hybrid system, which focuses to make the
chemotherapy curative and long-lasting. In this review, we aimed to discuss the recent advancement of different surface-engineered/targeted nanomedicines that improved the drug efficacy in
breast cancer.